@Elijahjstacy@houmanhemmati@adamfeuerstein@bot go over all of Adam’s post on Capr, seems like he has always had insider knowledge of outcomes and to me this time his post seem more desperate. What do you think
@nicolasranieri_@optionscjp Spreads are a nightmare, no stop loss, trail stops, marker orders. Only limit orders. Can’t drag and move spreads either with legends.
@TJTheWheelDeal Also you cab collected about 3.6% yield on your cash collateral while its chillin. Little bonus . Not sure it’s the same with portfolio margin though.
@TJTheWheelDeal@FunOfInvesting TJ so you park your collateral in Money maker fund? Or does it do it automatically? Super easy 3.5% yield added to the prmemiums
Adam, if deramiocel was truly dead on arrival the FDA wouldn’t still be sitting on it this close to the PDUFA date. So what did your FDA insider actually say? You lean on those anonymous agency sources constantly, then act surprised when people notice the consistent direction of the coverage. Claiming you don’t short stocks doesn’t erase the track record of names that get the Feuerstein treatment and immediately sell off.
Just got off the phone with Congresswoman Diana Harshbarger’s office. She has been briefed on the most pressing concern facing the DMD community and understands what’s at stake.
Congresswoman Harshbarger is Vice Chair of the Health Subcommittee and recently introduced the Right to Try for Individualized Treatments Act in the House.
KEEP HOPE ALIVE! 🇺🇸
The Capricor adcomm shows why temporary voting members need real disease expertise.
John Teerlink was the temporary cardiology voter. His background is general heart failure, not Duchenne cardiomyopathy.
He told the panel: “Whenever I see increases in volumes, that’s a no-go area… drugs that increase ventricular volumes actually end up hurting people.”
In adult heart failure that framing can make sense. In advanced DMD, progressive dilation is the natural history — stabilizing or reducing LV volumes is often seen as positive remodeling. Applying a general heart-failure rule as an automatic red flag is exactly the expertise gap temporary members are supposed to close.
The Capricor adcomm shows why temporary voting members need real disease expertise.
John Teerlink was the temporary cardiology voter. His background is general heart failure, not Duchenne cardiomyopathy.
He told the panel: “Whenever I see increases in volumes, that’s a no-go area… drugs that increase ventricular volumes actually end up hurting people.”
In adult heart failure that framing can make sense. In advanced DMD, progressive dilation is the natural history — stabilizing or reducing LV volumes is often seen as positive remodeling. Applying a general heart-failure rule as an automatic red flag is exactly the expertise gap temporary members are supposed to close.